Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 3/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.37 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 4/20 | 0.33 |
| ▸ | CNR2 | P34972 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | CNR1 | P21554 | 2/20 | 0.31 |
| ▸ | PTGES | O14684 | 1/20 | 0.30 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
| ▸ | PPARG | P37231 | 1/20 | 0.30 |
| ▸ | PPARA | Q07869 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6552393 | 0.78 | SMN1; SMN2 (0.41) | ESR1ESR2KIF11L3MBTL1 | |
| SCHEMBL27793924 | 0.74 | ESR1 (0.53) | ESR1ESR2TSHRALOX5HTT | |
| SCHEMBL27812039 | 0.74 | ESR1 (0.53) | ESR1ESR2TSHRALOX5HTT | |
| SCHEMBL27791053 | 0.74 | ESR1 (0.53) | ESR1ESR2TSHRALOX5HTT | |
| SCHEMBL27812038 | 0.74 | ESR1 (0.53) | ESR1ESR2TSHRALOX5HTT | |
| SCHEMBL27793591 | 0.74 | ESR1 (0.53) | ESR1ESR2TSHRALOX5HTT | |
| SCHEMBL27862084 | 0.74 | ESR1 (0.53) | ESR1ESR2TSHRALOX5HTT | |
| SCHEMBL27791055 | 0.74 | ESR1 (0.53) | ESR1ESR2TSHRALOX5HTT | |
| SCHEMBL27715178 | 0.74 | L3MBTL1 (0.33) | ESR1ESR2TSHRL3MBTL1HTT | |
| SCHEMBL27395824 | 0.72 | CNR2 (0.35) | HRH3CNR2TSHRCNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230414512-A1 | Dermal Delivery Compositions Comprising Active Agent-Calcium Phosphate Particle Complexes and Methods of Using the Same | LABORATORY SKIN CARE, INC. | 2023-12-28 | — | — | US | disclosed |
| EP-4218718-A2 | DERMAL DELIVERY COMPOSITIONS COMPRISING ACTIVE AGENT-CALCIUM PHOSPHATE PARTICLE COMPLEXES AND METHODS OF USING THE SAME | Laboratory Skin Care, Inc. (US) | 2023-08-02 | — | — | EP | disclosed |
| EP-2427178-B1 | DERMAL DELIVERY COMPOSITIONS COMPRISING ACTIVE AGENT-CALCIUM PHOSPHATE PARTICLE COMPLEXES AND METHODS OF USING THE SAME | LABORATORY SKIN CARE INC (US) | 2023-01-04 | — | — | EP | disclosed |
| US-20210220276-A1 | Methods of Treating Skin | LABORATORY SKIN CARE, INC. | 2021-07-22 | — | — | US | disclosed |
| EP-3771335-A1 | REPELLENT COMPOSITION | Athenion AG (CH) | 2021-02-03 | — | — | EP | disclosed |
| EP-3771336-A1 | REPELLENT COMPOSITION | Athenion AG (CH) | 2021-02-03 | — | — | EP | disclosed |
| US-20200138718-A1 | Dermal Delivery Compositions Comprising Active Agent-Calcium Phosphate Particle Complexes and Methods of Using the Same | LABORATORY SKIN CARE, INC. | 2020-05-07 | — | — | US | disclosed |
| US-10350168-B2 | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same | LABORATORY SKIN CARE, INC. (US) | 2019-07-16 | — | — | US | disclosed |
| US-20170340566-A1 | Dermal Delivery Compositions Comprising Active Agent-Calcium Phosphate Particle Complexes and Methods of Using the Same | LABORATORY SKIN CARE, INC. | 2017-11-30 | — | — | US | disclosed |
| US-9707177-B2 | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same | LABORATORY SKIN CARE, INC. (US) | 2017-07-18 | — | — | US | disclosed |
| US-20030114562-A1 | Tinting composition and method of use | PENNZOIL-QUAKER STATE COMPANY | 2003-06-19 | — | — | US | disclosed |
| EP-1303260-A2 | LINKAGE OF AGENTS USING MICROPARTICLES | Pericor Science, Inc. (US) | 2003-04-23 | — | — | EP | disclosed |
| WO-2003002674-A1 | COATING COMPOSITION | PENNZOIL-QUAKER STATE COMPANY (US) | 2003-01-09 | — | — | WO | disclosed |
| US-20030004241-A1 | Use of copolymers based on acrylamidoalkylsulfonic acids as thickeners in preparations comprising organic solvents | CLARIANT GMBH | 2003-01-02 | — | — | US | disclosed |
| EP-1251142-A1 | Use of copolymers based on acrylamidoalkylenesulphonic acid as thickener in compositions containing an organic solvent | Clariant GmbH (DE) | 2002-10-23 | — | — | EP | disclosed |
| EP-1203141-A1 | LINKAGE OF AGENTS TO TISSUE | Pericor Science, Inc. (US) | 2002-05-08 | — | — | EP | disclosed |
| EP-1202706-A1 | LYSINE OXIDASE LINKAGE OF AGENTS TO TISSUE | Pericor Science, Inc. (US) | 2002-05-08 | — | — | EP | disclosed |
| WO-2002007707-A2 | LINKAGE OF AGENTS USING MICROPARTICLES | PERICOR SCIENCE, INC. (US) | 2002-01-31 | — | — | WO | disclosed |
| WO-2001007009-A1 | LYSINE OXIDASE LINKAGE OF AGENTS TO TISSUE | PERICOR SCIENCE, INC. (US) | 2001-02-01 | — | — | WO | disclosed |
| WO-2001006829-A2 | LINKAGE OF AGENTS TO TISSUE | PERICOR SCIENCE, INC. (US) | 2001-02-01 | — | — | WO | disclosed |